Literature DB >> 17468403

Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.

Chetan Mukhtyar, Dimitrios Boumpas, Caroline Gordon, Wolfgang Gross, David Jayne, Raashid Luqmani.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17468403      PMCID： PMC1954609          DOI： 10.1136/ard.2006.065854

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  17 in total

1.  A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).

Authors:  J H Stone; G S Hoffman; P A Merkel; Y I Min; M L Uhlfelder; D B Hellmann; U Specks; N B Allen; J C Davis; R F Spiera; L H Calabrese; F M Wigley; N Maiden; R M Valente; J L Niles; K H Fye; J W McCune; E W St Clair; R A Luqmani
Journal:  Arthritis Rheum       Date:  2001-04

2.  The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary.

Authors:  J F Fries; G G Hunder; D A Bloch; B A Michel; W P Arend; L H Calabrese; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

Review 5.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

Authors:  J C Jennette; R J Falk; K Andrassy; P A Bacon; J Churg; W L Gross; E C Hagen; G S Hoffman; G G Hunder; C G Kallenberg
Journal:  Arthritis Rheum       Date:  1994-02

6.  The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.

Authors:  K de Groot; D Adu; C O Savage
Journal:  Nephrol Dial Transplant       Date:  2001-10       Impact factor: 5.992

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

Authors:  E M Hay; P A Bacon; C Gordon; D A Isenberg; P Maddison; M L Snaith; D P Symmons; N Viner; A Zoma
Journal:  Q J Med       Date:  1993-07

Review 9.  Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Authors:  Robert S Flanc; Matthew A Roberts; Giovanni F M Strippoli; Steven J Chadban; Peter G Kerr; Robert C Atkins
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

10.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.